Page last updated: 2024-10-24

cefuroxime and Active Hyperemia

cefuroxime has been researched along with Active Hyperemia in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research Excerpts

ExcerptRelevanceReference
"Cefuroxime has some theoretical advantages over gentamicin in its antibacterial spectrum."2.67Randomised single blind trial to compare the toxicity of subconjunctival gentamicin and cefuroxime in cataract surgery. ( Jenkins, CD; McDonnell, PJ; Spalton, DJ, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jenkins, CD1
McDonnell, PJ1
Spalton, DJ1

Trials

1 trial available for cefuroxime and Active Hyperemia

ArticleYear
Randomised single blind trial to compare the toxicity of subconjunctival gentamicin and cefuroxime in cataract surgery.
    The British journal of ophthalmology, 1990, Volume: 74, Issue:12

    Topics: Cataract Extraction; Cefuroxime; Conjunctiva; Conjunctival Diseases; Edema; Endophthalmitis; Eye Hem

1990